Anzeige
Mehr »
Login
Sonntag, 19.01.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Edison Investment Research

ZeitAktuelle NachrichtenRatingLeser
FrCivitas Social Housing - Strong financial and social returns continuing147H120 results showed strong year-on-year growth in rental income and earnings. Dividend cover is increasing and full cover is in sight, with debt facilities in place to fund further portfolio growth...
► Artikel lesen
FrAuriant Mining - Tardan CIL de-risks Kara-Beldyr100After a few months of delays, Auriant Mining's Tardan CIL project has now been operating since mid-November. Production guidance for FY19 is 550kg from the Tardan heap leach operation and 150kg from...
► Artikel lesen
DoFidelity European Values - Disciplined process driving outperformance107Fidelity European Values (FEV) is managed by Sam Morse, who selects stocks on a bottom-up basis, focusing on quality companies with strong balance sheets that are able to grow dividends over the long...
► Artikel lesen
Do4imprint Group - Self-promotion pays1314imprint's pre-close update indicates trading in the later weeks of the full year continued strong, with FY19 results set to be at the higher end of the market forecast range. Revenue (+17%) was slightly...
► Artikel lesen
MiSecure Trust Bank - Positive pre-close93Secure Trust Bank's (STB) pre-close trading update indicates that FY19 results should be in line with expectations, despite the economic slowdown dampening loan demand in the second half of 2019. STB...
► Artikel lesen
MiGames Workshop Group - 'Record sales and profit' again 166Games Workshop's (GAW) interim results are ahead of expectations. The highest rates of revenue growth were achieved in the channels with the highest operating margins, ie Trade (40% margin) and Online...
► Artikel lesen
DiPaion - Acacia to sell ByFavo in US854Acacia Pharma will sell ByFavo (remimazolam) in the US after a deal with Cosmo (Paion's Switzerland-based US partner). Cosmo estimates 24.5m endoscopy procedures per year. Acacia may launch its first...
► Artikel lesen
DiIQE - Leading innovation from within142The breadth of IQE's technology portfolio and ability to serve compound semiconductor chip customers in the US and Asia puts it in a good position to benefit from rising demand for compound semiconductor...
► Artikel lesen
DiOsirium Technologies - Bookings ahead of expectations111Osirium made good progress in signing new business in H2, reporting FY19 bookings 13% ahead of our forecast and 53% higher year-on-year. FY19 revenue is slightly below our forecast due to the timing...
► Artikel lesen
DiCarr's Group - Engineering pipeline to offset weather challenges94Carr's trading update for the first 18 weeks of FY20 notes that while trading in Agriculture was lower than expected, primarily because of the mild UK weather, the strong Engineering pipeline should...
► Artikel lesen
DiDeutsche Beteiligungs - Guidance beat assisted by a successful exit187NAV to be up to 10% lower (vs the current €472.1m as defined by DBAG), but more than 20% higher income from the fund services segment (FY19: €3.0m). The latter should be driven by the recent launch...
► Artikel lesen
DiBoku - Payments profits support Identity growth93Boku's FY19 trading update confirmed that it met consensus expectations for revenue and EBITDA, albeit aided by recognition of one-off revenues of $3.2m in H2. The Payments business showed strong underlying...
► Artikel lesen
DiGamesys Group - Top end of consensus110Gamesys has reported a positive pre-close trading update following a strong final quarter. The company expects FY19 pro-forma revenue and adjusted EBITDA to reach the top end of consensus estimates...
► Artikel lesen
MoAcacia Pharma - ByFavo deal to bolster pipeline136Acacia Pharma has announced a deal with Cosmo Pharmaceuticals to acquire the US rights to registrational phase asset ByFavo (remimazolam). The deal strengthens Acacia's product offering beyond key asset...
► Artikel lesen
MoKazia Therapeutics - An agile pivot196Kazia Therapeutics has announced that GDC-0084, its promising glioblastoma drug, will join (subject to definitive agreement) the pivotal GBM AGILE trial. AGILE is a clinician-led trial that currently...
► Artikel lesen
MoHenderson Far East Income - Access to Asian growth with solid 6% yield102Henderson Far East Income (HFEL) performed strongly in 2019, unusually outperforming a rising market while continuing to achieve a well-covered dividend and a yield in excess of 6%. The trust, managed...
► Artikel lesen
MoShield Therapeutics - Feraccru out-licensed in China147Shield Therapeutics has kick-started 2020 by securing an out-licensing deal in China for its primary asset, Feraccru/Accrufer. The exclusive deal with China-based Beijing Aosaikang Pharmaceutical (ASK...
► Artikel lesen
MoXP Power - Demand acceleration through Q419127While previously reported issues with an ERP upgrade limited the amount of product XP could ship in Q419, revenues for FY19 came in ahead of our forecast and XP closed the year with a strong order book...
► Artikel lesen
10.01.EQS Group - Compliance with growth story196EQS is making progress on its journey to become a fully embedded provider of investor relations and compliance platforms and products to corporate customers. While conversion of sales leads has been...
► Artikel lesen
10.01.Rockhopper Exploration - Sea Lion funding outlook strengthened199Rockhopper (RKH) has announced that, together with Premier Oil, it has signed Heads of Terms with Navitas Petroleum to farm down a 30% interest in the Sea Lion project. The deal increases confidence...
► Artikel lesen
09.01.Fluence Corporation - Financial close for Ivory Coast135Fluence has announced financial close on its Ivory Coast project. While there was little doubt this would be achieved at some point, it reduces uncertainty and enables at least US$20m in revenue to...
► Artikel lesen
09.01.Silence Therapeutics - Solving disease by targeting genes with siRNA158We are initiating coverage of Silence Therapeutics (SLN), a developer of siRNA drugs for diseases that can be genetically targeted. Silence has a proprietary platform for developing siRNA therapeutics...
► Artikel lesen
08.01.Greggs - 'A very strong finish to a spectacular year'138Greggs finished 2019 with accelerating revenue growth. It continues to benefit from increasing customer growth as the brand strengthens and it takes share in the 'food-on-the-go' market. With increased...
► Artikel lesen
08.01.1Spatial - Update suggests performance is on track1341Spatial's update suggests the momentum the business was enjoying at the time of the capital markets day in October has been sustained to the end of the calendar year. While no financial figures are...
► Artikel lesen
08.01.Avacta Group - New JV gives further validation to Affimers138Avacta has announced a joint venture with Daewoong Pharmaceuticals to develop mesenchymal stem cell (MSC) therapies incorporating Affimers. The joint venture (JV), will be based in South Korea and entirely...
► Artikel lesen